Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women

Allan Hildesheim(National Institutes of Health), Mark Schiffman(National Institutes of Health), Patti E. Gravitt(National Institutes of Health), Andrew G. Glass(National Institutes of Health), Catherine E. Greer(National Institutes of Health), T Zhang(National Institutes of Health), David R. Scott(National Institutes of Health), Brenda B. Rush(National Institutes of Health), P.G. Lawler(National Institutes of Health), Mark E. Sherman(National Institutes of Health), R. J. Kurman(National Institutes of Health), M. Michele Manos(National Institutes of Health)
The Journal of Infectious Diseases
February 1, 1994
Cited by 688

Abstract

Determinants of genital human papillomavirus (HPV) persistence in 393 women initially cytologically normal were investigated by testing them for HPV DNA twice over a median interval of 14.9 months. At each visit, interview information was obtained and a cervicovaginal lavage sample was collected for polymerase chain reaction-based HPV testing. Twenty-six percent of the women were HPV-positive at the first sampling. Data on HPV type was available for 86 HPV-positive women (84%); 35 of these women (41%) had persistent type-specific HPV detection. Persistence decreased with time between samplings. Women aged > or = 30 years had a higher percentage of persistence (65%) than those < or = 24 years (32%, P = .02). The percentage of persistence was higher among women infected with HPV types known to be cancer-associated (45%) than among those infected with other types (24%, P = .11). These findings were independent of each other and of timing between samplings. Although based on a prevalent cohort, these results are concordant with previous suggestions that HPV infection is usually transient and that cervical cancer may arise from within the subset of women with persistent HPV infection.


Related Papers

No related papers found

Powered by citation graph analysis